{"id":34889,"date":"2022-09-01T13:51:05","date_gmt":"2022-09-01T13:51:05","guid":{"rendered":"https:\/\/haberulus.net\/?p=34889"},"modified":"2022-09-01T13:51:05","modified_gmt":"2022-09-01T13:51:05","slug":"abden-omicron-asisina-yesil-isik","status":"publish","type":"post","link":"https:\/\/haberulus.net\/?p=34889","title":{"rendered":"AB\u2019den Omicron a\u015f\u0131s\u0131na ye\u015fil \u0131\u015f\u0131k"},"content":{"rendered":"<p><b>AB ila\u00e7 d\u00fczenleyicisi kurumu EMA, Covid varyantlar\u0131na y\u00f6nelik a\u015f\u0131lar\u0131n kullan\u0131m\u0131na ye\u015fil \u0131\u015f\u0131k yakt\u0131. A\u00e7\u0131klamada, mRNA teknolojisiyle geli\u015ftirilmi\u015f ve vir\u00fcslere adapte edilmi\u015f a\u015f\u0131lar\u0131n Covid-19 hastal\u0131\u011f\u0131na kar\u015f\u0131 daha geni\u015f koruma sa\u011flad\u0131\u011f\u0131 kaydedildi.<\/b><\/p>\n<div>\n<div>\n<p>Avrupa Birli\u011fi\u2019nin (AB) ila\u00e7 d\u00fczenleyicisi Avrupa \u0130la\u00e7 Kurumu (EMA), Moderna ve Pfizer-BioNTech taraf\u0131ndan varyantlara uyumlu \u015fekilde geli\u015ftirilen Covid-19 a\u015f\u0131lar\u0131n\u0131n AB i\u00e7inde kullan\u0131labilece\u011fine karar verdi.<\/p>\n<p>EMA\u2019dan yap\u0131lan a\u00e7\u0131klamada, takviye dozu olarak kullan\u0131labilecek a\u015f\u0131lar\u0131n 12 ya\u015f ve \u00fczerindeki ki\u015filerin \u201cOmicron BA.1\u201d varyant\u0131na kar\u015f\u0131 korunmas\u0131 amac\u0131yla kullan\u0131labilece\u011fi belirtildi. A\u00e7\u0131klamada, mRNA teknolojisiyle geli\u015ftirilmi\u015f ve vir\u00fcslere adapte edilmi\u015f a\u015f\u0131lar\u0131n Covid-19 hastal\u0131\u011f\u0131na kar\u015f\u0131 daha geni\u015f koruma sa\u011flad\u0131\u011f\u0131, Moderna ve Pfizer-BioNTech taraf\u0131ndan geli\u015ftirilen yeni a\u015f\u0131lar\u0131n BA.1 varyant\u0131na kar\u015f\u0131 \u00f6nceki a\u015f\u0131lardan daha etkili ba\u011f\u0131\u015f\u0131kl\u0131k tepkisi sa\u011flayabildi\u011fi kaydedildi.<\/p>\n<p><strong>TAVS\u0130YE N\u0130TEL\u0130\u011e\u0130 TA\u015eIYOR<\/strong><\/p>\n<p>A\u015f\u0131lar\u0131n yan etkilerinin de \u00f6nceki orijinal a\u015f\u0131larla benzerlik g\u00f6sterdi\u011fi ve k\u0131sa s\u00fcrede ortadan kalkt\u0131\u011f\u0131 ifade edildi. Her iki firman\u0131n orijinal Covid-19 a\u015f\u0131lar\u0131n\u0131n da hala hastal\u0131\u011f\u0131 a\u011f\u0131r ge\u00e7irmeyi, hastaneye kald\u0131r\u0131lmay\u0131 ve \u00f6l\u00fcmleri engellemede etkili oldu\u011fu, bunlar\u0131n \u00f6zellikle ilk kez a\u015f\u0131lanacaklar i\u00e7in a\u015f\u0131 kampanyalar\u0131nda kullan\u0131lmaya devam edece\u011fi vurguland\u0131.<\/p>\n<p>EMA\u2019n\u0131n ayr\u0131ca Omicron BA.4 ve BA.5 gibi di\u011fer varyantlara uyumlu olacak \u015fekilde geli\u015ftirilen ba\u015fka a\u015f\u0131larla ilgili incelemelerinin devam etti\u011fi bildirildi.<\/p>\n<p>EMA\u2019n\u0131n a\u015f\u0131larla ilgili kararlar\u0131 AB komisyonu i\u00e7in tavsiye niteli\u011fi ta\u015f\u0131yor. A\u015f\u0131lar\u0131n AB i\u00e7inde kullan\u0131m\u0131na AB Komisyonu onay veriyor. EMA\u2019n\u0131n Covid-19 a\u015f\u0131lar\u0131yla ilgili tavsiyeleri bug\u00fcne kadar AB Komisyonu taraf\u0131ndan k\u0131sa s\u00fcrede onayland\u0131. (AA)<\/p>\n<\/div>\n<\/div>\n","protected":false},"excerpt":{"rendered":"<p>AB ila\u00e7 d\u00fczenleyicisi kurumu EMA, Covid varyantlar\u0131na y\u00f6nelik a\u015f\u0131lar\u0131n kullan\u0131m\u0131na ye\u015fil \u0131\u015f\u0131k yakt\u0131. A\u00e7\u0131klamada, mRNA teknolojisiyle &#8230;<\/p>\n","protected":false},"author":1,"featured_media":34890,"comment_status":"closed","ping_status":"open","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[30],"tags":[180,7068,1224],"class_list":["post-34889","post","type-post","status-publish","format-standard","has-post-thumbnail","hentry","category-saglik","tag-asi","tag-asilarin","tag-covid"],"_links":{"self":[{"href":"https:\/\/haberulus.net\/index.php?rest_route=\/wp\/v2\/posts\/34889","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/haberulus.net\/index.php?rest_route=\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/haberulus.net\/index.php?rest_route=\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/haberulus.net\/index.php?rest_route=\/wp\/v2\/users\/1"}],"replies":[{"embeddable":true,"href":"https:\/\/haberulus.net\/index.php?rest_route=%2Fwp%2Fv2%2Fcomments&post=34889"}],"version-history":[{"count":1,"href":"https:\/\/haberulus.net\/index.php?rest_route=\/wp\/v2\/posts\/34889\/revisions"}],"predecessor-version":[{"id":34891,"href":"https:\/\/haberulus.net\/index.php?rest_route=\/wp\/v2\/posts\/34889\/revisions\/34891"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/haberulus.net\/index.php?rest_route=\/wp\/v2\/media\/34890"}],"wp:attachment":[{"href":"https:\/\/haberulus.net\/index.php?rest_route=%2Fwp%2Fv2%2Fmedia&parent=34889"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/haberulus.net\/index.php?rest_route=%2Fwp%2Fv2%2Fcategories&post=34889"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/haberulus.net\/index.php?rest_route=%2Fwp%2Fv2%2Ftags&post=34889"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}